Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer-Reference-Cited by-同舟云学术

Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer

Published:2018-10 Issue:10 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Valcarcel-Jimenez Lorea,Macchia Alice,Martín-Martín Natalia,Cortazar Ana Rosa,Schaub-Clerigué Ariane,Pujana-Vaquerizo Mikel,Fernández-Ruiz Sonia,Lacasa-Viscasillas Isabel,Santos-Martin Aida,Loizaga-Iriarte Ana,Unda-Urzaiz Miguel,Hermanova Ivana,Astobiza Ianire,Graupera Mariona,Starkova Julia,Sutherland James^ORCID,Barrio Rosa^ORCID,Aransay Ana M.^ORCID,Carracedo Arkaitz^ORCID,Torrano Verónica

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-018-1096-6.pdf

Reference68 articles.

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

2. Martin-Martin, N., Carracedo, A. & Torrano, V. Metabolism and transcription in cancer: Merging Two Classic Tales. Front. Cell Dev. Biol. 5, 119 (2017).

3. Martin-Martin, N. et al. Stratification and therapeutic potential of PML in metastatic breast cancer. Nat. Commun. 7, 12595 (2016).

4. Martin-Martin, N. et al. PPARdelta elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth. Cancer Res. 78, 399–409 (2018).

5. Bacolod, M. D. et al. Examination of epigenetic and other molecular factors associated with mda-9/syntenin dysregulation in cancer through integrated analyses of public genomic datasets. Adv. Cancer Res. 127, 49–121 (2015).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients;Discover Oncology;2023-12-19

2. Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer;Cancer Discovery;2023-09-07

3. Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features;International Journal of Molecular Sciences;2023-07-25

4. MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF;International Journal of Molecular Sciences;2023-01-17

5. The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis;Frontiers in Surgery;2023-01-13